Posted in | News | Solar Energy

SunEdison Completes Construction of 100 MW Utility-Scale Solar Power Plants in the U.K.

SunEdison, a leading solar technology manufacturer and provider of solar energy services announced today that it has completed construction of a 100 MW (megawatt) DC (direct current) portfolio utility-scale photovoltaic (PV) solar power plants across the United Kingdom. The portfolio is composed of seven separate solar power plants.

"We just entered the U.K. solar market this year and have already interconnected seven plants," said Jose Perez, president of SunEdison Europe, Africa and Latin America. "This is a testament to our ability to enter a new market and efficiently execute projects that add to the company's bottom line. We attribute much of our success to our ability to find highly-qualified local vendors to partner with. They provide localized expertise while helping us support the local job market."

SunEdison recently signed a 15-year power purchase agreement (PPA) with Statkraft, a market-leading purchaser of independently generated electricity in the UK. Under the terms of the PPA Statkraft will purchase the renewable energy generated from an 88 MW DC portfolio of six utility-scale photovoltaic solar power plants SunEdison is currently constructing throughout the U.K.

About SunEdison

SunEdison is a global leader in semiconductor and solar technology. SunEdison's semiconductor business has been a pioneer in the design and development of silicon wafer technologies for over 50 years. With R&D and manufacturing facilities in the U.S., Europe and Asia, SunEdison enables the next generation of high performance semiconductor devices. SunEdison's solar business develops, finances, installs and operates distributed power plants, delivering predictably priced solar energy and services for its commercial, government and utility customers. SunEdison's common stock is listed on the New York Stock Exchange under the symbol "SUNE." To learn more visit www.sunedison.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.